Union of India , W.P.(C) 8773/2025 (pdf), the DHCs Division Bench (DB) comprising Chief Justice Devendra Kumar Upadhyay and Justice Tushar Rao Gedela, expressed serious concern over the misuse of these drugs while disposing of a public interest litigation (PIL) that raised alarm over the off-label and unregulated use of powerful anti-diabetic drugs like Ozempic (semaglutide), Mounjaro (tirzepatide) and Victoza (liraglutide) for weight loss
This study was approved by the IACUC of KBI prior to the experimental phase, under IACUC protocol number KBI K001121061-01,01
Always inform your doctor about all medicines you are taking to avoid potential interactions
and CTRP6, C1q/tumour necrosis factorrelated protein 6
Whether you took the medication for blood sugar control or significant weight loss doesnt affect your right to seek compensation for gastroparesis, vision loss, or other injuries caused by the drug